One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papershttps://doi.org/10.1136/ijgc-2019-esgo.10
Copy DOI Publication Date: Nov 1, 2019 |
Affiliation: Fondazione IRCCS Istituto Nazionale dei Tumori, Goethe University Frankfurt, Centre Léon Bérard, Hospital Universitario Ramón y Cajal, Kliniken Essen-Mitte, Arcagy Gineco, Spanish Ovarian Cancer Research Group, MD Anderson Cancer Center Madrid, Institut Bergonié, Jena University Hospital, European Institute of Oncology, Centre Jean Perrin, Istituti di Ricovero e Cura a Carattere Scientifico, University Medical Center Hamburg-Eppendorf, Universität Hamburg, Saitama Medical University, Tampere University, Paracelsus Medical University, KU LeuvenPhase III PAOLA-1/ENGOT-ov25 trial: olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer treated with platinum-based chemotherapy plus bevacizumab
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
